Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors

Enoyl acyl carrier protein (ACP) reductase (FabI) is a potential target for the development of antibacterial agents. Three-dimensional quantitative structure-activity relationships (3D-QSAR) for substituted formamides series of FabI inhibitors were investigated using comparative molecular field anal...

Full description

Bibliographic Details
Main Authors: Qidong You, Ke Ding, Kun Huang, Man Lv, Xiaoyun Lu
Format: Article
Language:English
Published: MDPI AG 2012-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/13/6/6620
id doaj-34354c765f5043b8a82f0f6f644ac557
record_format Article
spelling doaj-34354c765f5043b8a82f0f6f644ac5572020-11-24T21:24:56ZengMDPI AGInternational Journal of Molecular Sciences1422-00672012-05-011366620663810.3390/ijms13066620Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) InhibitorsQidong YouKe DingKun HuangMan LvXiaoyun LuEnoyl acyl carrier protein (ACP) reductase (FabI) is a potential target for the development of antibacterial agents. Three-dimensional quantitative structure-activity relationships (3D-QSAR) for substituted formamides series of FabI inhibitors were investigated using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques. Pharmacophore and molecular docking methods were used for construction of the molecular alignments. A training set of 36 compounds was performed to create the 3D-QSAR models and their external predictivity was proven using a test set of 11 compounds. Graphical interpretation of the results revealed important structural features of the formamides related to the active site of FabI. The results may be exploited for further optimization of the design of new potent FabI inhibitors.http://www.mdpi.com/1422-0067/13/6/6620FabI inhibitorspharmacophoremolecular docking3D-QSARCoMFACoMSIA
collection DOAJ
language English
format Article
sources DOAJ
author Qidong You
Ke Ding
Kun Huang
Man Lv
Xiaoyun Lu
spellingShingle Qidong You
Ke Ding
Kun Huang
Man Lv
Xiaoyun Lu
Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
International Journal of Molecular Sciences
FabI inhibitors
pharmacophore
molecular docking
3D-QSAR
CoMFA
CoMSIA
author_facet Qidong You
Ke Ding
Kun Huang
Man Lv
Xiaoyun Lu
author_sort Qidong You
title Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
title_short Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
title_full Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
title_fullStr Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
title_full_unstemmed Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
title_sort pharmacophore and molecular docking guided 3d-qsar study of bacterial enoyl-acp reductase (fabi) inhibitors
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2012-05-01
description Enoyl acyl carrier protein (ACP) reductase (FabI) is a potential target for the development of antibacterial agents. Three-dimensional quantitative structure-activity relationships (3D-QSAR) for substituted formamides series of FabI inhibitors were investigated using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques. Pharmacophore and molecular docking methods were used for construction of the molecular alignments. A training set of 36 compounds was performed to create the 3D-QSAR models and their external predictivity was proven using a test set of 11 compounds. Graphical interpretation of the results revealed important structural features of the formamides related to the active site of FabI. The results may be exploited for further optimization of the design of new potent FabI inhibitors.
topic FabI inhibitors
pharmacophore
molecular docking
3D-QSAR
CoMFA
CoMSIA
url http://www.mdpi.com/1422-0067/13/6/6620
work_keys_str_mv AT qidongyou pharmacophoreandmoleculardockingguided3dqsarstudyofbacterialenoylacpreductasefabiinhibitors
AT keding pharmacophoreandmoleculardockingguided3dqsarstudyofbacterialenoylacpreductasefabiinhibitors
AT kunhuang pharmacophoreandmoleculardockingguided3dqsarstudyofbacterialenoylacpreductasefabiinhibitors
AT manlv pharmacophoreandmoleculardockingguided3dqsarstudyofbacterialenoylacpreductasefabiinhibitors
AT xiaoyunlu pharmacophoreandmoleculardockingguided3dqsarstudyofbacterialenoylacpreductasefabiinhibitors
_version_ 1725985983334187008